[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Xtrades Analysts Team [@TradingXtrades](/creator/twitter/TradingXtrades) on x 2923 followers Created: 2025-07-24 10:42:16 UTC Shares of $ABVX rocketed higher by XXX% Wednesday after the small biotech unveiled "potentially disruptive" results for its experimental ulcerative colitis treatment, obefazimod. A potential takeover, he said, noting Merck $MRK Roche $RHHBY Pfizer $PFE and Eli Lilly $LLY XXX engagements  **Related Topics** [$lly](/topic/$lly) [$rhhby](/topic/$rhhby) [acquisition](/topic/acquisition) [$abvx](/topic/$abvx) [stocks](/topic/stocks) [$mrk](/topic/$mrk) [stocks healthcare](/topic/stocks-healthcare) [$pfe](/topic/$pfe) [Post Link](https://x.com/TradingXtrades/status/1948332902435197030)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Xtrades Analysts Team @TradingXtrades on x 2923 followers
Created: 2025-07-24 10:42:16 UTC
Shares of $ABVX rocketed higher by XXX% Wednesday after the small biotech unveiled "potentially disruptive" results for its experimental ulcerative colitis treatment, obefazimod.
A potential takeover, he said, noting Merck $MRK Roche $RHHBY Pfizer $PFE and Eli Lilly $LLY
XXX engagements
Related Topics $lly $rhhby acquisition $abvx stocks $mrk stocks healthcare $pfe
/post/tweet::1948332902435197030